BioSyntech, Inc.
BSYI · OTC
12/31/2009 | 9/30/2009 | 6/30/2009 | 3/31/2009 | |
|---|---|---|---|---|
| Market Cap | $12 | $12 | $12 | $16 |
| - Cash | $1 | $1 | $2 | $4 |
| + Debt | $17 | $14 | $13 | $12 |
| Enterprise Value | $28 | $26 | $23 | $24 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -99.6% | 119.2% | 132% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -80.4% | 67.7% | 59.3% | 69.7% |
| EBITDA | -$3 | -$3 | -$3 | -$4 |
| % Margin | -638,779.8% | -2,898.3% | -4,582.1% | -18,540.1% |
| Net Income | -$3 | -$4 | -$3 | -$3 |
| % Margin | -664,083.3% | -3,007.2% | -4,837.7% | -12,955% |
| EPS Diluted | -0.032 | -0.032 | -0.035 | -0.031 |
| % Growth | 2.8% | 6.9% | -11.9% | – |
| Operating Cash Flow | -$2 | -$2 | -$2 | -$2 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2 | -$2 | -$2 | -$2 |